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Proper organ homeostasis requires tight control of
adult stem cells and differentiation through the inte-
gration of multiple inputs. In the mouse small intes-
tine, Notch and Wnt signaling are required both for
stem cell maintenance and for a proper balance
of differentiation between secretory and absorptive
cell lineages. In the absence of Notch signaling,
stem cells preferentially generate secretory cells at
the expense of absorptive cells. Here, we use func-
tion-blocking antibodies against Notch receptors to
demonstrate that Notch blockade perturbs intestinal
stem cell function by causing a derepression of the
Wnt signaling pathway, leading to misexpression of
prosecretory genes. Importantly, attenuation of the
Wnt pathway rescued the phenotype associated
with Notch blockade. These studies bring to light
a negative regulatory mechanism that maintains
stem cell activity and balanced differentiation, and
we propose that the interaction between Wnt and
Notch signaling described here represents a com-
mon theme in adult stem cell biology.
INTRODUCTION
The mouse intestinal epithelium provides an important model
for studying tissue renewal. Continuous turnover of the epithe-
lium is supported by intestinal stem cells (ISCs) located near the
base of the crypts. Genetic lineage tracing studies have led to
the identification of distinct ISC populations, including crypt
base columnar cells (CBCs) that are marked by Lgr5, a Wnt
target gene (Barker et al., 2007). CBCs reside at the bottom of
crypts, occupying cell positions +1 through +5 from the base,
where they are intercalated between postmitotic Paneth cells,
which constitute the stem cell niche (Sato et al., 2011). CBCs
contribute to all intestinal cell types, including the secretory
and absorptive lineages, through rapidly proliferating interme-diates known as transit-amplifying (TA) cells (Barker et al.,
2007).
Both development of the small intestine and homeostasis
of the adult intestine require canonical Wnt signaling (Fevr
et al., 2007; Korinek et al., 1998; van Es et al., 2012). Conversely,
misexpression of the Wnt signaling agonists R-spondin1-4
(Rspo1-4) leads to enhanced activation of b-catenin and
increased proliferation in the small intestine (Kim et al., 2006).
Lgr5 and its homologs Lgr4 and Lgr6 associate with Rspos to
enhance Wnt signaling (de Lau et al., 2011; Ruffner et al.,
2012). The central role of Wnt signaling is highlighted by the
Wnt-dependent expression of numerous ISC markers, including
Lgr5 (de Lau et al., 2011). Beyond its role in maintaining
ISCs, Wnt signaling confers competence for the secretory fate
decision. Specifically, Wnt signaling plays a role in Paneth cell
differentiation (Andreu et al., 2005; van Es et al., 2005a), and
overexpression of the Wnt inhibitor Dkk1 leads to loss of all
secretory cells (Pinto et al., 2003).
The Notch pathway affects intestinal homeostasis by regu-
lating CBCs and by promoting the absorptive cell fate. Compro-
mising Notch signaling in adult mice with the g-secretase inhib-
itor DAPT, which blocks conversion of the Notch receptor into a
transcriptionally active molecule, causes a loss of proliferating
Lgr5-positive CBCs and an overall increase in secretory cells
(VanDussen et al., 2012). Secretory cell hyperplasia in the gut
also occurs with deletion of the Notch effector Rbp-j (van Es
et al., 2005b). Genetic evidence indicates that Notch signaling
negatively regulates secretory cell differentiation through repres-
sion of Math1/Atoh1 (Yang et al., 2001) because conditional
deletion of Math1 rescues the Rbp-j loss of function phenotype
(Kim and Shivdasani, 2011). However, while Math1 is upregu-
lated in the absence of Notch (VanDussen et al., 2012), the sig-
nal(s) required for positively maintaining normal levels of Math1
in the small intestine is unknown.
Although Notch and Wnt signaling have been studied individ-
ually, how these pathways are integrated to maintain ISCs and
to regulate cell fate choices for ISC progeny is unknown.
Here, using Notch blocking antibodies, we have found that a
principal function of Notch signaling in maintaining ISCs is its
ability to dampen Wnt signaling output. Notch blockade causedCell Reports 11, 33–42, April 7, 2015 ª2015 The Authors 33
Figure 1. Distribution of Wnt and Notch
Signaling in Crypts of the Mouse Small In-
testine
(A) Lgr5GFP (green) and Axin2LacZ (red) expression
are co-incident in CBCs (arrows).
(B) Axin2LacZ (red) overlaps with Edu incorporation
(green) in cells at the base of the crypt (arrows) and
in TA cells (asterisks) adjacent to CBCs.
(C) Axin2LacZ expression (red) overlaps with
secretory cell progenitors marked by Math1GFP
(green, arrowheads).
(D) The active form of Notch1 (NICD, red) is local-
ized to the nuclei of CBCs (green, arrows).
(E) NICD (red) overlaps with Ki67 staining (green) in
CBCs (arrows) and TA cells (asterisks).
(F) Notch signaling (red) is absent from secretory
progenitor cells (green).conversion of Lgr5-expressing ISCs to secretory cells, leading to
stem cell depletion. This coincided with Wnt pathway upregula-
tion and increased secretory cell differentiation. The attenuation
of canonical Wnt signaling rescued the Notch phenotype,
demonstrating that the secretory cell metaplasia caused by
Notch loss of function was due to upregulation of WNT ligand
production.
RESULTS
Localization of Wnt and Notch Signaling in the Intestinal
Crypt
To begin to investigate the role of the Notch andWnt pathways in
maintaining crypt homeostasis, we determined which cells
within the crypts receive Notch and Wnt signals. We detected
expression of Lgr5GFP and the Wnt reporter Axin2LacZ in CBCs
(Figures 1A and 1B), and strong Axin2LacZ expression was de-
tected in proliferating cells near the border of the stem cell
compartment and TA zone (Figure 1B). The Atoh1/Math1 gene
is required for the specification of secretory cell progenitors in
the small intestine (VanDussen and Samuelson, 2010; Yang
et al., 2001). Approximately 76% of the crypts that we analyzed
showed thatMath1GFP expression also overlapped with the Wnt
reporter in cells near the border of the stem cell compartment
and TA zone (Figure 1C, arrowheads; n = 3, R100 crypts per
mouse analyzed).
Lgr5 is a Wnt target gene and an established marker of CBCs.
We found that CBCs marked by Lgr5GFP were also positive for
the transcriptionally active form of Notch (NICD) (Figure 1D),
confirming that the Notch pathway is active in ISCs. Nuclear
NICD staining was also detected in TA cells closest to the crypt
bottom (Figure 1E, asterisks). NICD staining and the secretory
progenitor markerMath1GFP never overlapped in these cells (Fig-
ure 1F; n = 3,R100 crypts per sample analyzed), consistent with
the role of Notch signaling in induction of absorptive lineages
(Fre et al., 2005; van Es et al., 2005b). These results reinforce
the notion that both the Wnt and Notch pathways are active
in CBCs. However, the complete lack of NICD in Math1GFP
and Axin2LacZ double-positive progenitors reaffirms that Notch34 Cell Reports 11, 33–42, April 7, 2015 ª2015 The Authorssignaling and Wnt signaling also have divergent functions during
cell fate specification.
Notch Signaling Blockade Impairs ISC Function
Based on the observations that both theNotch andWnt signaling
pathways are active in ISCs, we set out to test their respective
roles by reducing the levels of signaling. To block the activity
of NOTCH receptors 1 and 2, we employed therapeutic anti-
bodies that specifically inhibit the activity of NOTCH1 and
NOTCH2 in vivo (Wu et al., 2010). Inhibition of NOTCH1 and
NOTCH2 together effectively blocked Notch signaling, based
on a complete loss of NICD accumulation in ISCs and TA
cells (Figures 2A and 2B). NOTCH inhibition also decreased pro-
liferation associated with the TA zone (Figures 2C, 2D, and S2E)
and substantially increased expression of the Paneth cell
marker lysozyme, an indication of the switch from an absorptive
to secretory cell fate (Figures 2E, 2F, and S2F). Thus, our
dosing scheme effectively blocked Notch signaling in the small
intestine.
We next examined the ISCmarkers Lgr5 andOlfm4 at different
time points during the Notch blockade. Lgr5 and Olfm4 were
downregulated 7 hr after NOTCH antibody treatment (Figures
S1A–S1D, S1I, and S1J). Expression of Olfm4, a Notch target
gene (VanDussen et al., 2012), remained downregulated during
the entire Notch blockade (Figures S1J–S1L). Lgr5 expression,
along with proliferating CBCs, was greatly reduced 24 hr after
Notch blockade (Figures 3C, 3K, S1E, and S1F). Surprisingly,
Lgr5 expression recovered 72 hr later, became ectopically ex-
pressed throughout the crypt base, and extended upward to
the region normally occupied by TA cells (Figures S1G and
S1H). This finding is consistent with the activation of Lgr5 in
newly formed Paneth cells (Buczacki et al., 2013). By day 6,
Lgr5GFP and lysozyme staining were strongly upregulated in
crypts (Figures 2D and 2F).
We next examined the effect of partial Wnt inhibition on small
intestine homeostasis by treating mice with an antibody de-
signed to block the activity of the Wnt co-receptor LRP6 (Exper-
imental Procedures). Treatment of mice with anti-LRP6 antibody
led to a marked reduction in Axin2LacZ staining (Figures 2G and
2H), consistent with the functional role of LRP6 in transducing
Wnt signaling in the gut (Zhong et al., 2012). Wnt signaling is
required for secretory cell differentiation (Farin et al., 2012; Pinto
et al., 2003), and we focused our attention on the specification of
the secretory lineage in anti-LRP6-treated mice. Consistent with
our observation that Axin2LacZ overlaps with Math1GFP expres-
sion, anti-LRP6 treatment also resulted in loss of these
Math1GFP-positive secretory progenitor cells (Figures 2G, 2H,
and S2G). Paneth cells, which are long lived (Ireland et al.,
2005), were maintained in the presence of anti-LRP6 treatment
(Figure S2J). We observed a decrease in the average number
of short-lived goblet cells per villus compared with controls
(6.5 compared with 10.5 goblet cells per villus; n = 3, R49 villi
per sample analyzed). Anti-LRP6 treatment also led to the loss
of Lgr5GFP expression in CBCs while maintaining normal crypt
proliferation in the intestine (Figures 2I, 2J, and S2H). This result
indicates that the anti-LRP6 blocking antibody inhibits but does
not abrogate Wnt signaling, and it reinforces the idea that
different Wnt signaling thresholds are required to maintain Lgr5
expression versus maintaining proliferation. Interestingly, we
observed a near complete downregulation of Axin2LacZ levels
in mice treated with anti-LRP6 blocking antibody (Figure 2H),
suggesting that the levels of Wnt signaling remaining during
anti-LRP6 treatment are not sufficient to drive Axin2LacZ expres-
sion. We did not observe an effect on NICD staining in the anti-
LRP6-treated mice (Figures 2K, 2L, and S2I).
To definitively determine whether CBCs require Notch
and Wnt signaling to give rise to differentiated cells, we per-
formed genetic lineage tracing experiments using Lgr5CreER/+;
RosaRFP/+ mice. First, mice were given Notch blocking anti-
bodies before induction of recombination with Tamoxifen
(TAM). Compared with control mice (Figure 2M), treatment with
Notch blocking antibodies before TAM induction completely pre-
vented lineage tracing from Lgr5-expressing cells (Figure 2N).
RFP-marked cells were present at the crypt base (Figure 2N,
inset) and expressed the secretory marker lysozyme (Fig-
ure S2B), indicating that CBCs had converted into Paneth cells
during Notch blockade. In addition, we injected Notch blocking
antibodies following Tam-induced recombination. Under these
conditions, lineage tracing from the base of the crypts was
almost completely absent, with patchy lineage tracing remaining
in cells near the top of villi (Figure 2O). RFP marked cells were
also detected at the crypt base (Figure 2O, inset) and expressed
lysozyme (Figure S2D), indicating that a small population of
CBCs had given rise to Paneth cells during Notch blockade.
Together, these results show that Notch signaling is required
for CBC stem cell activity.
Treating mice with LRP6 blocking antibody before induction
with Tam caused a complete loss of Lgr5 lineage tracing events
(Figure 2P). To differentiate between a defect in stem cell activity
and suppression of Lgr5 expression throughWnt signaling atten-
uation, we next induced recombination in CBCs followed by
LRP6 blocking antibody treatments. This led to uninterrupted
lineage tracing similar to that observed in control mice (Fig-
ure 2Q), indicating that CBC stem cells function normally under
LRP6 signaling attenuation and that the loss of lineage tracing
seen in the pre-Tam treatments was likely due to loss of Lgr5
expression. These results, together with the presence of prolifer-ating CBCs and Olfm4 expression in the anti-LRP6-treated
animals (Figures 2J and S1M), highlight the ability of the anti-
LRP6 treatment to uncouple Lgr5 expression from CBC stem
cell activity.
Notch Blockade Leads to Wnt Signaling Upregulation,
which Promotes Secretory Cell Hyperplasia
The downregulation ofMath1GFP expression by administration of
the LRP6 blocking antibody is consistent with a role for Wnt
signaling in promotion of secretory cell fate decisions. We de-
tected downregulation of Math1GFP expression as early as
24 hr after anti-LRP6 injection (Figure 3N). This led us to examine
Wnt signaling readouts during Notch blockade. By 7 hr after in-
jection with the Notch blocking antibodies, intestinal crypts
showed a pronounced increase in Axin2LacZ expression (Figures
3A and 3E) without an apparent increase inMath1GFP expression
(Figures 3B and 3F). Notch signaling represses Math1 in the in-
testine (Fre et al., 2005; van Es et al., 2005b), and we detected
a substantial increase in Math1GFP expression by 24 hr post
treatment (Figures 3J and 3Y). Interestingly, at this time point,
Math1GFP-positive cells overlapped with the increased Axin2LacZ
expression (Figure 3J), indicating that the Notch secretory hyper-
plasia phenotype correlated with cells that were actively under-
going high levels of Wnt signaling.
These observations prompted us to perform gene expression
analysis using microarrays followed by quantitative PCR (qPCR)
validation on intestinal crypts from mice treated with Notch
blocking antibodies for 24 hr (Figure 3Y; Tables S2, S3, and
S4). The top differentially expressed genes were bona fide Notch
targets (Olfm4 (log2[fold change] = 4.07)) and Neurog3 (log2
[fold change] = 3.83) (Fre et al., 2005; VanDussen et al., 2012).
In addition, we also detected upregulation of Wnt3 as well as
several known Wnt target genes and regulators of secretory
cell differentiation. Within the set of anti-Notch upregulated
genes, two groups were distinguished based on responsiveness
to co-treatment with anti-LRP6. One group showed a greater
than 2-fold decrease in expression and included Wnt3 and
Atoh1/Math1 (Table S4), whereas the other showed minimal
responsiveness to anti-LRP6 treatment and included Pax4 (<2-
fold; Table S5). Several of the minimally responsive genes have
been identified previously in screens for Wnt target genes (de
Lau et al., 2011), suggesting that treatment with the anti-LRP6
antibody represents an incomplete Wnt signaling blockade. In
addition, other established Wnt targets, Sox9 and EphB3, were
also increased during the early Notch blockade (Figures 3D,
3H, and 3L). Thus, immunofluorescence and microarray results
indicated that Notch signaling attenuatesWnt signaling, prevent-
ing secretory differentiation in the intestinal epithelium. Next, we
set out to address the function of Notch and the mechanism of
Wnt inhibition.
Wnt Signaling Upregulation Occurs Independently of
Paneth Cell Hyperplasia
Paneth cells are a major source of Wnt3 in the small intestine,
which led us to ask if Paneth cell hyperplasia represents the
solemechanism bywhichWnt signaling upregulation is achieved
during Notch blockade. Levels of the Paneth cell marker Defa1
(data not shown) and lysozyme staining in the small intestineCell Reports 11, 33–42, April 7, 2015 ª2015 The Authors 35
Figure 2. Loss of Notch Signaling Perturbs the Function of Lgr5-Positive Stem Cells
(A) Control crypts show a normal distribution of NICD staining in CBCs and TA cells.
(B) NICD immunostaining is absent from crypts treated with Notch1 and Notch2 (aN1/N2) blocking antibodies over 6 days.
(C) Control crypts show a normal distribution of Lgr5GFP expression in proliferating CBCs and a subset of TA cells (arrows).
(D) Notch blockade causes an increase in Lgr5GFP expression (green) and a decrease in proliferating cells (red) in the TA zone.
(E) Lgr5-positive CBCs (green) are largely non-overlapping with lysozyme-positive Paneth cells (red).
(legend continued on next page)
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(Figures S3A and S3B) were not significantly increased at the 24-
hr time point. To test whether Paneth cells are required for a Wnt
response, we blocked Notch signaling in VillinCre;Math1fl/flmice
that lack both secretory progenitors as well as differentiated
secretory cells, including Paneth cells. Villin Cre;Math1fl/fl mice
had significantly reduced levels of Defa1 that did not change
with Notch blockade (Figure S3C). Tissue samples from the
same region of intestine had increased Ki67 and SOX9 staining
(Figures S3D–S3J), which indicated that Wnt signaling was
upregulated even in the absence of the Wnt3 contribution from
Paneth cells. To test for alternative sources of Wnt signaling acti-
vation, we examined the levels of Wnt target genes, Wnt iso-
forms, and Rspondin1-4 in the intestines of Villin Cre;Math1fl/fl-
treated mice. Although Wnt3 was not upregulated in treated
mice lacking Paneth cells (Figure S3K), we observed a consis-
tent upregulation of several Wnt target genes (Figure 3Z), as
well as mesenchyme-derived Wnt5a and epithelium-derived
Wnt9b (Figure 3Z’). In addition, theWnt signaling agonist Rspon-
din-4 (Rspo4) was significantly increased in both WT and Villin-
Cre;Math1fl/fl mice treated with NOTCH blocking antibodies
(Figures S3M and 3Z’). Thus, although the Paneth cells are an
important source of Wnt proteins when Notch signaling is
blocked in control mice, the small intestine can still mount a
Wnt response in the absence of Paneth cells. Moreover, activa-
tion of the Wnt pathway due to loss of Notch signaling in control
mice results at least in part from an initial amplification of Wnt
signaling through upregulation of the canonical ligand Wnt9b
and Wnt signaling agonist Rspo4. Wnt3 production stemming
from ongoing Paneth cell hyperplasia may then lock in place
the secretory cell fate decision.
Cotreatment with Wnt Blocking Antibodies Rescues
Secretory Cell Metaplasia Induced by Anti-Notch
To functionally test whether Wnt attenuation could prevent the
secretory cell metaplasia induced by Notch inhibition, we
analyzed secretory cell differentiation and stem cell activity while
simultaneously blocking Notch signaling and attenuating Wnt
signaling. We observed that the increased goblet cell content
and reduced crypt proliferation seen in Notch antibody-treated
animals were restored to normal levels in mice co-treated with
LRP6 blocking antibody (Figures 4A–4D). Thus, co-blockade of
Wnt and Notch signaling prevents secretory metaplasia and re-
stores intestinal homeostasis. As a definitive test of CBC stem
cell activity, we treated Lgr5CreER;RosaRFP mice with both Notch
and LRP6 blocking antibodies after induction of recombination
with Tam and found that co-treatment led to a dramatic rescue(F) Increased lysozyme-expressing cells (red) are present after 6 days aN1/N2 tr
(G) Control crypts showing distribution of Wnt signaling (Axin2LacZ, red) and secr
(H) aLRP6 treatment downregulates Axin2LacZ (red) and Math1GFP (green).
(I) Control crypts showing Lgr5GFP (green) and proliferating Ki67-positive cells (re
(J) Wnt attenuation with aLRP6 blocking antibody downregulates Lgr5GFP expr
arrows).
(K and L) Treatment with aLRP6 does not affect the distribution of NICD.
(M) Lineage tracing experiments using Lgr5CreER/+;RosaRFP/+ mice show widespr
(N) Treatment with aN1/N2 before and after induction with TAM causes decreas
(O) Lgr5-positive stem cells were first induced to undergo recombination with TA
(P) aLRP6 treatment causes a loss of lineage tracing from Lgr5-positive cells if p
(Q) aLRP6 treatment does not affect lineage tracing if provided after induction wof CBC proliferation (Figure 3S) and stem cell activity (Figure 4F).
Importantly, CBCs in this context no longer express the stem cell
markers Lgr5 (inset, Figure 4F) and Olfm4 (Figure S1N), indi-
cating that these markers are dispensable for stem cell activity.
Together, these data implicate upregulated Wnt signaling as
the mechanism that underlies secretory metaplasia when levels
of Notch signaling are reduced.
To complement the above experiments, we also tested
whether a decoy Wnt receptor, Frizzled 8 CRD (F8CRD) (Exper-
imental Procedures), could similarly rescue the effect of Notch
antibody blockade. As with single agent anti-LRP6 treatment,
F8CRD treatment led to downregulation of Wnt signaling, as as-
sessed by Axin2LacZ, and secretory differentiation, as assessed
by Math1GFP (Figure S4). Combined treatment with Notch anti-
bodies and F8CRD led to complete rescue of the secretory
metaplasia phenotype (Figures 4G and 4H), reinforcing the
notion that Notch blockade leads to secretory conversion in
large part through driving an increase in Wnt signaling via upre-
gulation of Wnt ligand expression. Importantly, this treatment
combination also rescued the weight loss and lethality induced
by Notch blocking antibodies (Figure S4S). Additional experi-
ments will be required to fully understand whether rescue of
the weight loss associated with Notch blockade is due specif-
ically to a shift in the balance of differentiated cells toward the
secretory fate.
DISCUSSION
Notch Signaling Antagonizes Wnt Signaling to Maintain
Stem Cell Activity
Previous studies have found that Notch activity plays an essen-
tial role in maintaining CBCs and TA cell proliferation while pre-
venting secretory differentiation (van Es et al., 2005b; VanDus-
sen et al., 2012). Our data indicate that Notch signaling is
active in CBCs and TA cells and is absent from all secretory pro-
genitors and their differentiated progeny. Using function block-
ing antibodies against Notch receptors, we found an upregula-
tion of Wnt signaling shortly after Notch blockade, indicating
that Notch signaling antagonizes Wnt signaling in the intestinal
epithelium. This finding has surprising implications for how Wnt
signaling normally regulates the maintenance and activity of
CBC stem cells. First, when Wnt signaling is elevated due to
Notch blockade, CBC activity and proliferation in the crypt are
severely compromised. These phenotypes are likely mediated
through increased Wnt ligand expression, particularly Wnt3,
and not other downstream components of the Wnt signalingeatment.
etory cell progenitors (Math1GFP, green).
d).
ession (absence of green staining) without affecting proliferating CBCs (red,
ead labeling of crypts and villi 7 days post induction with TAM.
ed lineage tracing from Lgr5-positive cells.
M and then treated with aN1/N2 on days 1 and 4.
rovided before induction with TAM.
ith TAM.
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pathway, as CBC activity and TA cell proliferation could be
rescued by attenuating Wnt signaling at the ligand and receptor
level with either anti-LRP6 or F8CRD. Second, attenuation of
normal Wnt signaling levels with anti-LRP6 or F8CRD had no ef-
fect on stem cell activity, such that diminished levels of Wnt
signaling were sufficient for normal stem cell function. Together,
these results indicate that Notch activity is required for maintain-
ing the proper level of Wnt signaling in the crypt that allows for
the simultaneous maintenance and activity of ISCs as well as
crypt proliferation.
Our experiments with the anti-LRP6 antibody point to a differ-
ential requirement for Wnt signaling in ISC self-renewal and
secretory differentiation, which may reflect functional differ-
ences between the LRP6 and LRP5 receptors. Wnt signaling
attenuation in our studies caused downregulation of secretory
differentiation, while leaving CBC stem cell activity intact. This
points to a model in which lower levels of Wnt signaling are
needed for stem cell maintenance and higher levels for secretory
cell differentiation, which is similar to the gradient of Wnt activity
seen in other systems, such as in hair follicle stem cell mainte-
nance and differentiation (Blanpain and Fuchs, 2006). However,
ISCs are embedded in aWNT-rich environment (Gregorieff et al.,
2005), which implies that CBCs should receive the highest levels
of Wnt signaling. Our analysis of Wnt activity, as assessed by the
Axin2lacZ reporter, shows that cells near the border of the stem
cell compartment express Axin2lacZ as strongly as or even higher
than CBCs (Figures 1A–1C). Based on these observations and
together with our findings that the highest intensity of nuclear
NICD occurs in CBCs and that high expression of the Notch
target gene Olfm4 also occurs in CBCs, we propose that the
lower level of Wnt signaling needed for ISC activity is achievedFigure 3. Notch Blockade Leads to Wnt Signaling Upregulation
(A) Control crypts showing Axin2LacZ staining (red).
(B) Combined Axin2LacZ (red) and Math1GFP (green) staining.
(C) Control crypts showing expression of Lgr5GFP (green) and proliferating cells (
(D) Control crypts showing antibody staining of the Wnt targets SOX9 (red) and E
(E) The 7-hr time point during Notch blockade shows an increase in the Wnt rep
(F) The 7-hr time point shows a normal distribution of Math1GFP relative to contro
(G) At 7-hr time point during Notch blockade, Lgr5GFP-positive CBCs are still pre
(H) The 7-hr time point during Notch blockade shows increasing intensity of SOX
(I) The 24-hr time point during Notch blockade shows an increased in Axin2LacZ
(J) The 24-hr time point during Notch blockade shows an increased distribution
(K) At the 24-hr time point during Notch blockade, Lgr5GFP (green) and proliferat
(L) The 24-hr time point during Notch blockade shows increased staining and di
(M and N) The 24-hr time point during LRP6 blockade shows absence of Axin2La
point to residual Math1GFP expression.
(O) The 24-hr time point during LRP6 blockade shows an absence of Lgr5GFP (g
(P) The 24-hr time point during LRP6 blockade shows near complete downregul
(Q) The 7-hr time point during combined Notch/LRP6 blockade shows a reduced
(R) The 7-hr time point during combined Notch/LRP6 blockade shows rescued o
(S) The 7-hr time point during combined Notch/LRP6 blockade shows a loss of Lg
the crypt.
(T) The 7-hr time point during combined Notch/LRP6 blockade shows the Wnt ta
(U) The 24-hr time point during combined Notch/LRP6 blockade shows that Axin
(V) The 24-hr time point during combined Notch/LRP6 blockade shows that Mat
(W) The 24-hr time point during combined Notch/LRP6 blockade shows a rescu
(X) The 24-hr time point during combined Notch/LRP6 blockade shows that the
(Y) Fold changes in gene expression relative to controls after antibody treatment
(Z) Relative levels of Wnt target gene expression in Villin Cre;Math1fl/fl mice treat
(Z’) Levels of Wnt5a, Wnt9b, and Rspo4 increase in Villin Cre;Math1fl/fl mice treathrough the antagonistic activity of Notch signaling. In line with
this hypothesis, Notch blockade caused an increase in Axin2LacZ
expression throughout the crypt, with a particular increase in in-
tensity detected at the crypt base (Figures 3E and 3I), along with
aberrant secretory cell differentiation and a complete loss of ISC
activity. The exact mechanism underlying the collaboration be-
tween Notch andWnt signaling in maintenance of ISCs is still un-
known, but our rescue experiments suggest that Notch signaling
is dispensable for ISC activity as long as theWnt signaling output
approximates normal levels (Figure 4F).
Anti-LRP6 or F8CRD treatment alone did not cause a reduc-
tion in CBC activity and TA proliferation while suppressing Wnt
target genes. Potential explanations for why these reagents do
not completely eliminate Wnt signaling include technical rea-
sons, such as an inability of F8CRD to completely titrate all
WNT3 ligand, or partial blockade of Wnt signaling by the anti-
LRP6 antibody; alternatively, signaling events initiated by
compensating Wnt pathway components may play a role.
Notch and Wnt Signaling Interplay Controls Cell
Differentiation
Math1/Atoh1, which is negatively regulated by Notch signaling,
is the key mediator of secretory metaplasia after Notch loss of
function (Kazanjian et al., 2010). In addition to rescuing secretory
cell metaplasia, Math1 deletion also restored proliferation after
Notch blockade, suggesting that Math1-mediated cell cycle
exit is a factor in maintaining crypt homeostasis. We found that
attenuation of the Wnt pathway by treatment with anti-LRP6
restored the normal distribution of Math1-expressing cells, and
this treatment rescued the Notch phenotype, including restora-
tion of proliferation. Importantly, the notion that increased WntKi67, red).
PHB3 (green) at the base of the crypt.
orter Axin2LacZ.
ls.
sent but have stopped proliferating (arrows).
9 positive nuclei at the base of the crypt (red).
staining.
of Math1GFP staining (green).
ing cells (red) are largely absent from the base of the crypt.
stribution of the Wnt targets SOX9 and EPHB3.
cZ (M, red) and loss of Math1GFP expression (N) in treated crypts. Arrows in (N)
reen) and a normal distribution of Ki67 staining in CBCs (arrows).
ation of the Wnt targets SOX9 and EPHB3.
distribution of Axin2LacZ relative to Notch blockade alone (E).
f Math1GFP expression pattern.
r5GFP expression and a rescued distribution of Ki67-positive cells at the base of
rget genes Sox9 and EphB3 remain downregulated.
2LacZ expression is reduced relative to (I).
h1GFP expression is reduced relative to (J).
ed distribution of Ki67-positive cells including CBCs (arrows).
Wnt target genes Sox9 and EphB3 remain downregulated.
s. mRNA was purified from isolated crypts. Results are mean ± SEM.
ed with Notch blocking antibodies.
ted with Notch blocking antibodies.
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Figure 4. Cotreatment with Notch and Wnt Blocking Antibodies Rescues Secretory Cell Metaplasia and ISC Activity
(A) Control ileum showing proliferating cells (Ki67, brown) and Alcian Blue stained Goblet cells.
(B) Notch blockade causes goblet cell metaplasia.
(C) aLRP6 treatment leads to no significant changes in the distribution of Goblet cells or proliferating cells.
(D) Combined aN1/N2 and aLRP6 treatment rescues the proliferation defects and Goblet cell metaplasia associated with Notch blockade alone.
(E) Lineage tracing experiments using Lgr5CreER/+;RosaRFP/+ mice with fully labeled crypts and villi at 7 days postinduction with TAM. Inset shows expression of
Lgr5GFP at crypt base.
(legend continued on next page)
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signaling mediates the Notch phenotype through upregulation of
Math1 is substantiated by the observation that LRP6 blockade
represses Math1 expression on its own and that Wnt/b-catenin
signaling directly regulates Math1 expression in other contexts
(Shi et al., 2010). We also found that the upregulation of Axin2lacZ
and other Wnt target genes preceded the activation of Math1
and secretory cell metaplasia. During Notch blockade, the small
intestine increases the production of Wnts as well as the agonist
Rspo4 in the absence of Math1 and the secretory cell lineage.
This strongly suggests that the trigger for secretory cell meta-
plasia in Notch-deficient mice is an immediate hyperactivation
of the Wnt pathway. Our data, together with previous studies,
indicate that Notch activity is required for maintaining the correct
balance of Wnt signaling in the crypt, which allows for simulta-
neous maintenance of ISCs, proliferation, and differentiation.
Notch/Wnt Interaction in Other Contexts
The interaction between Wnt and Notch signaling described
here may be a common theme in stem cell biology. For example,
deletion of the Notch1 receptor in mouse skin causes inappro-
priate activation of Wnt/b-catenin signaling in the epidermis
and impaired differentiation in primary keratinocytes, as well
as excess b-catenin accumulation in the eye epithelium lead-
ing to Wnt-dependent hyperproliferation (Nicolas et al., 2003).
Because Notch signaling plays diverse roles in organ homeosta-
sis and Notch/Wnt interactions may be prevalent in other sys-
tems, we cannot conclude that rescue of the Notch blockade
induced weight loss and lethality by F8CRD is the result of secre-
tory cell metaplasia suppression alone. In fact, anti-LRP6 treat-
ments in combination with Notch antibodies gave similar results
in terms of secretory cell metaplasia suppression; however,
these mice continued to lose weight at a similar rate compared
with treatment with anti-Notch alone. We speculate that the
F8CRD acts less broadly than the LRP6 blockade, and therefore,
this reagent is able to rescue the effects in the intestine without
causing other problems for the animal. Our work indicates that
Notch signaling normally serves as a natural brake on the Wnt
pathway and that attenuation of Notch signaling releases the
brake and allows for high levels of Wnt signaling. Thus, in certain
contexts, it may be beneficial to attenuate Notch signaling in or-
der to assist Wnt-mediated injury repair and stem cell-fueled
regeneration.
Finally, the interaction between Wnt and Notch signaling in
ISCs has important implications for the use of Notch pathway in-
hibitors. Intestinal goblet cell metaplasia is a major challenge in
the development of therapies that block Notch signaling, such
as the g-secretase inhibitors that hold promise for the treatment
of Alzheimer disease or of cancers that are caused by mutations
in the NOTCH pathway. The intestinal metaplasia disrupts
nutrient absorption, and animals succumb due to severe weight
loss. By modulation of Wnt signaling, it may be possible to over-
come the intestinal metaplasia toxicity and the lethality associ-
ated with Notch blockade. We propose that layering gentle(F) Combined aN1/N2 and aLRP6 treatment rescues stem cell activity, as indicat
shows representative fully labeled crypt with suppressed Lgr5GFP expression.
(G) Notch blockade causes goblet cell metaplasia.
(H) Combined aN1/N2 and aF8CRD treatment rescues the proliferation defects aattenuation of Wnt signaling on top of g-secretase inhibition or
other modalities that block Notch signaling can potentially over-
come the intestinal toxicity associated with such treatments,
thus allowing for long-term dosing with such agents.
EXPERIMENTAL PROCEDURES
Mice
All procedures were performed while observing University of California, San
Francisco regulations and guidelines. Please see Supplemental Information
for details about mouse use.
Immunohistochemistry and Immunofluorescence
Immunohistochemistry was performed using Dako Envision+ system-HRP
polymer detection kit. For immunofluorescence staining, samples were
blocked with Dako protein-free blocking solution. Primary and secondary
antibodies were diluted in Dako antibody diluent, and staining conditions
are summarized in Table S1. Secondary antibodies were from Jackson
Immunology.
Isolation of Crypts for qRT-PCR and Microarray Analysis
Four groups of C57Bl/6 mice were injected intraperitoneally with 1-mg/kg
Notch1 and Notch2 blocking antibodies, 30-mg/kg LRP6 blocking antibody,
1-mg/kg Notch1, Notch2 and 30-mg/kg LRP6 blocking antibodies, or
30-mg/kg anti-ragweed antibody. At 24 hr later, isolated small intestines
were opened longitudinally and washed with cold PBS. The tissue was then
chopped into 5-mm pieces and incubated in cold chelation buffer (2-mM
EDTA, 0.5-mM DL-DTT in PBS) for 30 min on ice. Chelation buffer was then
removed, and tissue fragments were vigorously resuspended in cold PBS us-
ing a 10-ml pipette. The process was repeated until individual crypts were
released from the tissue chunks. The crypt suspension fractions were pooled
and strained through a 70-micron filter. Crypts were pelleted, and RNAwas ex-
tracted using the QIAGEN RNeasy mini kit. See Supplemental Experimental
Procedures for array procedures.
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